Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Miller

Showing results (191-200 of 207) with videos related to

Pageof 21
Sort By:
Journal of Medicinal Chemistry|August 3, 2021
Optimization of the Urea Linker of Triazolopyridazine MMV665917 Results in a New Anticryptosporidial Lead with Improved Potency and Predicted hERG Safety MarginEdmund Oboh, Tanner J Schubert, Jose E Teixeira, et al.
Nature Communications|April 25, 2019
A suite of phenotypic assays to ensure pipeline diversity when prioritizing drug-like Cryptosporidium growth inhibitorsRajiv S Jumani, Muhammad M Hasan, Erin E Stebbins, et al.
Journal of Epidemiology and Global Health|June 23, 2023
The Impact of COVID-19 on Trends of Violence-Related Offences in AustraliaPeter Miller, Kira Button, Nicholas Taylor, et al.
BMC Public Health|November 13, 2018
Short-term changes in nightlife attendance and patron intoxication following alcohol restrictions in Queensland, AustraliaKerri Coomber, Renee Zahnow, Jason Ferris, et al.
Journal of Medicinal Chemistry|June 2, 2023
Structure-Activity Relationship Studies of the Aryl Acetamide Triazolopyridazines against Tanner J Schubert, Edmund Oboh, Hannah Peek, et al.
Nano Letters|February 21, 2013
Optical, structural, and numerical investigations of GaAs/AlGaAs core-multishell nanowire quantum well tubesMelodie Fickenscher, Teng Shi, Howard E Jackson, et al.
Nature Communications|September 27, 2024
Identification of potent and orally efficacious phosphodiesterase inhibitors in Cryptosporidium parvum-infected immunocompromised male miceJubilee Ajiboye, José E Teixeira, Makafui Gasonoo, et al.
Drug and Alcohol Review|July 22, 2014
A comparative study of blood alcohol concentrations in Australian night-time entertainment districtsPeter Miller, Amy Pennay, Nicolas Droste, et al.
Nature Communications|June 29, 2019
Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosisChristopher S Lunde, Erin E Stebbins, Rajiv S Jumani, et al.
American Journal of Respiratory and Critical Care Medicine|May 27, 2006
Intervention at the level of the neuroendocrine-immune axis and postoperative pneumonia rate in long-term alcoholicsClaudia Spies, Verena Eggers, Gyongyi Szabo, et al.
Pageof 21

Showing results (191-200 of 207) with videos related to

Sort By:
Pageof 21
Journal of Medicinal Chemistry|August 3, 2021
Optimization of the Urea Linker of Triazolopyridazine MMV665917 Results in a New Anticryptosporidial Lead with Improved Potency and Predicted hERG Safety MarginEdmund Oboh, Tanner J Schubert, Jose E Teixeira, et al.
Nature Communications|April 25, 2019
A suite of phenotypic assays to ensure pipeline diversity when prioritizing drug-like Cryptosporidium growth inhibitorsRajiv S Jumani, Muhammad M Hasan, Erin E Stebbins, et al.
Journal of Epidemiology and Global Health|June 23, 2023
The Impact of COVID-19 on Trends of Violence-Related Offences in AustraliaPeter Miller, Kira Button, Nicholas Taylor, et al.
BMC Public Health|November 13, 2018
Short-term changes in nightlife attendance and patron intoxication following alcohol restrictions in Queensland, AustraliaKerri Coomber, Renee Zahnow, Jason Ferris, et al.
Journal of Medicinal Chemistry|June 2, 2023
Structure-Activity Relationship Studies of the Aryl Acetamide Triazolopyridazines against Tanner J Schubert, Edmund Oboh, Hannah Peek, et al.
Nano Letters|February 21, 2013
Optical, structural, and numerical investigations of GaAs/AlGaAs core-multishell nanowire quantum well tubesMelodie Fickenscher, Teng Shi, Howard E Jackson, et al.
Nature Communications|September 27, 2024
Identification of potent and orally efficacious phosphodiesterase inhibitors in Cryptosporidium parvum-infected immunocompromised male miceJubilee Ajiboye, José E Teixeira, Makafui Gasonoo, et al.
Drug and Alcohol Review|July 22, 2014
A comparative study of blood alcohol concentrations in Australian night-time entertainment districtsPeter Miller, Amy Pennay, Nicolas Droste, et al.
Nature Communications|June 29, 2019
Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosisChristopher S Lunde, Erin E Stebbins, Rajiv S Jumani, et al.
American Journal of Respiratory and Critical Care Medicine|May 27, 2006
Intervention at the level of the neuroendocrine-immune axis and postoperative pneumonia rate in long-term alcoholicsClaudia Spies, Verena Eggers, Gyongyi Szabo, et al.
Pageof 21